Prediction and prevention of type 1 diabetes

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 87, Issue 425, 1998, Pages 54-62

  Knip, M ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autoantibodies; Genetic markers; Prediction; Prevention; Type 1 diabetes

Indexed keywords

CONFERENCE PAPER; FAMILY HISTORY; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SECONDARY PREVENTION;

EID: 0031752974     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1998.tb01254.x     Document Type: Conference Paper

References (64)

1. Cooke A. An overview on possible mechanisms of destruction of the insulin-producing beta cell. Curr Top Microbiol Immunol 1990; 164: 125-42
2. Thai AC, Eisenbarth GS. Natural history of IDDM. Diabetes Rev 1993; 1: 1-14
3. Knip M. Disease-associated immunity and prevention of insulin-dependent diabetes mellitus. Ann Med 1997; 29: 447-51
4. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984; 311: 149-52
5. Dahlquist G, Blom L, Holmgren G, Hägglöf B, Larsson Y, Sterky G, et al. The epidemiology of diabetes in Swedish children 0-14 years - a six-year prospective study. Diabetologia 1985; 28: 802-8
6. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio E, et al. Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 70-6
7. Wagener DK, Sacks JM, LaPorte RE, MacGregor JM. The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 1982; 31: 136-44
8. Tillil H, Köbberling J. Age-corrected empirical risk estimates for first degree relatives of IDDM patients. Diabetes 1987; 36: 93-9
9. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, et al. Predicting insulin-dependent diabetes. Lancet 1988; ii: 845-50
10. Pociot F, Norgaard K, Hobolth N, Andersen O, Nerup J, the Danish Study Group of Diabetes in Childhood. A nationwide population-based study of the familial aggregation of Type 1 (insulin-dependent) diabetes mellitus in Denmark. Diabetologia 1993; 36: 870-5
11. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-6
12. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161-4
13. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 371-7
14. Ilonen J, Reijonen H, Herva E, Sjöroos M, Iitiä A, Lövgren T, et al. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996; 19: 795-800
15. Ilonen J, Reijonen H, Knip M, Simell O. Population-based genetic screening for IDDM susceptibility as a source of HLA genotyped control subjects. Diabetologia 1996; 39: 123 (Letter)
16. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279-82
17. Lendrum R, Walker G, Gamble DR. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1975; i: 880-3
18. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-9
19. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-72
20. Knip M, Vähäsalo P, Karjalainen J, Lounamaa R, Åkerblom HK, the Study Group on Childhood Diabetes in Finland. Natural history of preclinical IDDM in high risk siblings. Diabetologia 1994; 37: 388-93
21. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9
22. Arslanian SA, Becker DJ, Rabin B, Atchison R, Eberhardt M, Cavender D, et al. Correlates of insulin autoantibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 1985; 32: 926-30
23. Karjalainen J, Knip M, Mustonen A, Ilonen J, Åkerblom HK. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 1986; 35: 620-2
24. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167-9
25. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6
26. r autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357-60
27. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen A, Sundquist G, et al. Glutamate decarboxylase-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-11
28. Sabbah E, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, et al. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1996; 81: 2455-9
29. Lan MS, Yasuhiro G, Notkins AL. Molecular cloning and identification of a receptor tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13: 505-14
30. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, et al. Islet cell antigen 512 is a diabetes-specific autoantigen related to protein tyrosine phosphatases. J Immunol 1994; 152: 3183-8
31. r tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA-512). J Clin Invest 1995; 96: 1506-11
32. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, et al. Predicting insulin-dependent diabetes. Lancet 1988; ii: 845-50
33. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-22
34. Karjalainen J, Vähäsalo P, Knip M, Tuomilehto-Wolf E, Virtala E, Åkerblom HK, et al. Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high- and low-risk siblings of diabetic children. Eur J Clin Invest 1996; 26: 640-9
35. Verge CF, Gianini R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 antibodies. Diabetes 1996; 45: 926-33
36. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes - a population-based study. J Clin Invest 1998; 101: 327-36
37. Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, et al. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1994; 16: 45-50
38. Knip M, Rahko J, Kulmala P, Vähäsalo P, Karjalainen J. Occurrence and persistence of IDDM-associated autoantibodies in unaffected school children. Diabetologia 1996; 39 (Suppl 1): A46 (Abstract)
39. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-10
40. Atkinson MA, Kaufman D, Campbell L, Gibbs KA, Shah SC, Bu DF, et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 1992; 339: 458-9
41. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341: 1365-9
42. Duronovic Bello I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45: 795-800
43. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First degree relatives of patients with Type 1 diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313: 461-4
44. Vardi P, Crisa L, Jackson RA, Dumont Herskowitz R, Wolsdorf JT, Einhorn D, et al. Predictive value of intravenous glucose tolerance test: Insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients. Diabetologia 1991: 34: 93-102
45. McCulloch DK, Klaff LJ, Kahn SE, Shoenfeld SL, Greenbaum CJ, Mauseth RS, et al. Nonprogression of subclinical β-cell dysfunction among first degree relatives of IDDM patients. 5-year follow-up of the Seattle family study. Diabetes 1990; 39: 549-56
46. Røder M, Knip M, Hartling SG, Karjalainen J, Åkerblom HK, Binder C, et al. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin response. J Clin Endocrinol Metab 1994; 79: 1570-5
47. Johnson SB, Tercyak KP Jr. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care 1995; 18: 1370-2
48. Pozzilli P. Prevention of insulin-dependent diabetes: where are we now? Diabetes Metab Rev 1996; 12: 127-35
49. Knip M, Åkerblom HK. IDDM prevention trials in progress - a critical assessment. J Pediatr Endocrinol Metab 1998; 11 (Suppl 2): 371-7
50. Åkerblom HK, Savilahti E, Saukkonen TT, Paganus A, Virtanen SM, Teramo K, et al. The case for elimination of cow's milk in early infancy in the prevention of Type 1 diabetes: the Finnish experience. Diabetes Metab Rev 1993; 9: 269-78
51. Bingley PJ, Knip M, Gale EAM. Designing an intervention study to delay or prevent the clinical onset of IDDM. Pediatr Adolescent Endocrinol 1993; 23: 147-56
52. Elliott RB, Pilcher CC, Ferguson DM, Stewart AW. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrinol Metab 1996; 9: 501-9
53. DPT-1 Study Group. The Diabetes Prevention Trial - Type 1 diabetes (DPT-1): progress report. Diabetologia 1997; 40 (Suppl 1): A66 (Abstract)
54. Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM. Diabetologia 1998; 41: 79-85
55. Knip M, Kulmala P, Vähäsalo P, Karjalainen J, Reijonen H, Ilonen J, et al. Seroconversion to autoantibody positivity before the age of 6 years in siblings of children with IDDM. J Pediatr Endocrinol Metab 1996: 9: 216 (Abstract)
56. Mandrup-Poulsen T, Reimers J, Andersen HU, Pociot F, Karlsen AE, Bjerre U, et al. Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1993; 9: 295-309
57. Lampeter EF for the DENIS Study Group. Intervention with nicotinamide in pre-type 1 diabetes: The Deutsche Nikotinamid Interventions Studie - DENIS. Diabete Metab 1993; 39: 105-9
58. Tjälve H, Wilander E. The uptake in the pancreatic islets of nicotinamide, nicotinic acid and tryptophan and their ability to prevent streptozotocin diabetes in mice. Acta Endocrinol 1976; 83: 357-64
59. Greenbaum CJ, Kahn SE, Palmer JP. Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes 1996; 45: 1631-4
60. Pozzilli P, Browne PD, Kolb H, the Nicotinamide Trialists. Meta-analysis of nicotinamide in patients with recent onset insulin dependent diabetes. Diabetes Care 1996; 19: 1357-63
61. Hoffer A. Safety, side effects and relative lack of toxicity of nicotinic acid and nicotinamide. Schizophrenia 1969; 1: 78-89
62. Blanas E, Carbone FR, Allison J, Miller JFAP, Heath WR. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996; 274: 1707-9
63. Zhang ZJ, Davidson L. Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88: 10252-6
64. American Diabetes Association Ad Hoc Expert Committee. Prevention of Type 1 diabetes mellitus. Position statement. Diabetes Care 1990; 9: 1026-7